Imported Plasma and Recombinant Products
Grant AT-CN3924657 — Direct Award
Amount
$30,209,374
Selection Process
Direct Award
Period
30 Sep 2022 — 29 Sep 2027
Approved: 02 Nov 2022
Purpose
Procurement method: Limited tender
Other Grants to Takeda Pharmaceuticals Australia Pty Ltd
| Grant | Program | Amount | Selection |
|---|---|---|---|
| National Supply arrangement for imported immunoglobulin products | National Blood Authority | $434,085,725 | Direct Award |
| Supply of Advate and Adynovate Imported Plasma and … | National Blood Authority | $109,458,800 | Direct Award |
| Procurement of Imported Plasma and Recombinant Products (IPRP) … | National Blood Authority | $22,323,958 | Open Competitive |
Data Source
Source: AusTender
Category: UNSPSC 51000000
State: NSW | Postcode: 2000